阜阳治疗荨麻疹便宜的医院在哪阜阳治灰指甲的价钱,阜阳治疗白斑的特效医院,阜阳做好的皮肤医院,阜阳什么医院青春痘,阜阳哪一里医院荨麻疹比较好,阜阳颍泉区哪里祛痘比较好,在阜阳青春痘哪家医院好

SAN FRANCISCO, June 8 (Xinhua) -- Facebook Inc. will be probed by European Union (EU) regulators over its latest facial recognition feature rolling out worldwide, U.S. media reported on Wednesday.The feature, called Tag Suggestions, uses face recognition software to match users' new photos to other photos they are tagged in. It groups similar photos together and suggests the name of the friend in the photos.Facebook rolled out the feature in the United States late last year, where users can opt out of the feature by going to their private settings. But Facebook switched it on by default without telling users first when it became available on Tuesday in countries outside of the United States.A group of privacy watchdogs from 27 EU nations will study the measure for possible rule violations, a Luxembourg official of Article 29 Data Protection Working Party told Bloomberg. The Working Party, an independent EU advisory body on data protection and privacy, comprises the data protection regulators of all the 27 EU member states."Tags of people on pictures should only happen based on people' s prior consent and it can't be activated by default," said the Luxembourg official, Gerald Lommel. He noted that such automatic features "can bear a lot of risks for users" and the European data- protection regulators will "clarify to Facebook that this can't happen like this."Authorities in Britain and Ireland said they are also looking into the new function on Facebook. The British Information Commissioner's Office told Bloomberg that "the privacy issues that this new software might raise are obvious," saying it is "speaking to Facebook" about the issue.Facebook has been under scrutiny by EU regulators for several privacy concerns, such as users' default settings and how the company uses the information collected from its social network website.

SAN FRANCISCO, June 28 (Xinhua) -- Google Android chief Andy Rubin said on Tuesday that the activations of Android-powered devices are growing at a rate of 4.4 percent on a weekly basis, with over 500,000 devices activated each day worldwide."There are now over 500,000 Android devices activated every day, and it's growing at 4.4 percent w/w," tweeted Rubin, Google's Senior Vice President of Mobile who oversees the development of Android, the open-source operating system for smartphones.Last month, Google said at its annual developer conference Google I/O that 400,000 Android devices were being activated each day, compared with 300,000 daily activations in December and 100, 000 in May 2010.More research data have shown Android system's soaring market share and popularity. Earlier this month, Internet market research company ComScore reported that Android remained the No. 1 smartphone operating system in the United States over the three months ending in April. The system captured 36.4 percent of U.S. smartphone subscribers, while Apple's iOS system for iPhone had 26 percent of all smartphone users.In April, market research company Gartner said in a forecast that the Android operating system will own 49.2 percent of the global smartphone market and Apple's iOS will have an 18.9-percent share in the second place.

BEIJING, Sep. 13 (Xinhuanet) --Experts have called for a national drug-control system after a nationwide deficit of a life-saving drug, which has lasted at least three months.Doctors at a Beijing hospital said some specialized hospitals, which perform hundreds of cardiac operations every month, have been paralyzed by their lack of protamine sulfate, which is commonly administered after heart surgery to reverse the anticoagulant effects of heparin.The earliest report of a shortage was in Hubei province on July 21. This was followed by reports of shortages in Guangdong, Shandong and Liaoning provinces.The Shandong newspaper, Qilu Evening News, quoted a regional sales manager, surnamed Zhuang, as saying the province had been allocated 150 doses of protamine sulfate after Shanghai No 1 Biochemical and Pharmaceutical Co Ltd recently resumed production of the drug."But its monthly use here is usually 10,000 doses," he said.The Ministry of Health has denied it is responsible for supplies of the drug and passed the buck to the State Food and Drug Administration, claiming the latter is responsible for the supervision of medicines.Shen Chen, head of the publicity office of the State Food and Drug Administration, said he was unaware of the shortage, but said the administration is responsible for the quality of medicines, not the supply."Development and reform authorities oversee the medicines' prices, while the industrial and commercial authorities oversee the storage. The food and drug departments only cover the approval and quality of medicines."Industry insiders said one of the reasons for the shortage was the low profit margin, which discourages companies from mass producing the drug."Some companies can't earn enough to recover their costs, therefore it is almost impossible to maintain their enthusiasm for continuing production," said Lu Guoping, secretary-general of the Shanghai Pharmaceutical Trade Association.Lu said the government should issue policies to prevent future shortages of such medicines to avoid possible nationwide public health incidents.Yi Shenghua, a lawyer at Beijing Yingke Law Firm, said the country should have a unified system to guarantee the normal supply of medicines that are widely used and drug manufacturers should fulfill their responsibilities to society, even though there is no law stipulating they should produce specific medicines.He came up with two ways to deal with the problem of companies only producing profitable drugs."The government can order businesses to manufacture a certain amount of cheap medicines. Or it can offer financial assistance to subsidize cheap, but life-saving medicines."

MOSCOW, Aug. 30 (Xinhua) -- Russia's space agency said Tuesday that a Proton-M rocket launch failed earlier this month because of a malfunction in the upper stage.The conclusion was reached by an independent investigation commission following a series of checks, Roscosmos said in a report that was posted on its website."The commission reported that the time span reserved for the gyrostabilized platform's turn was miscalculated and narrowed, which caused the Briz-M upper stage's disorientation and the satellite's journey to a wrong orbit," the agency said.Other systems in the upper stage performed well, the agency said, adding it has lifted a ban on launches of the Proton-M carrier rockets equipped with the Briz-M upper stage.Local media reported the Briz-M, manufactured by the Khrunichev State Research and Production Space Center, has had five failures over its 12-year history of operation.On Aug. 18, a Proton-M carrier rocket failed to deliver a communications satellite into orbit. After the failure, Russia suspended launches of Proton-M rockets pending the outcome of an investigation into the failure.

SAN FRANCISCO, Sept. 27 (Xinhua) -- Apple on Tuesday announced an invitation-only special event featuring iPhone on Oct. 4, 2011.With a simple headline reading "Let's talk iPhone," the invitation said that there will be an "executive presentation at 10 a.m.." This could be the first big product introduction by the newly installed Chief Executive Officer Tim Cook after he took over the reins of Apple from Steve Jobs in August.The event, which will be held at Apple campus in Cupertino, California, has long been reported to be the introduction of iPhone 5, the next generation iPhone.According to U.S. media reports, the iPhone 5 is expected to have revamped hardware design with a larger screen, a higher resolution camera and a faster dual-core A5 chip on which the iPad 2 runs. Apple is also reported to release a low-cost and contract- free iPhone model bundled with its cloud computing service iCloud.